Company intelligence
Isto Biologics
Dedicated to providing advanced solutions for spine, orthopedics, and sports medicine. #helpingpatientshealfaster
About Isto Biologics
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company’s best-in-class product offerings include Arteriocyte’s market-leading Magellan® Autologous Platelet Separator and Isto’s bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; and Influx™, a natural bone-graft material.
Verified activity
Signals from Isto Biologics
3 published signals
Presence & Recognition
Isto Biologics will be attending SMISS next week with Christopher Gump, Jared Diegmueller, and Gordon Peterson.
Reported by Kyle Monahan
Presence & Recognition
Isto Biologics is attending the AOFAS conference in Seattle to help advance foot and ankle patients heal faster.
Reported by J.R. Mikulak
Presence & Recognition
isto Biologics attended the Fall IDN Summit and is looking to connect with attendees.
Reported by Isto Biologics